<address id="333n5"></address>

            <address id="333n5"></address>

                  <address id="333n5"><nobr id="333n5"><meter id="333n5"></meter></nobr></address><form id="333n5"><listing id="333n5"></listing></form>


                  NKF has a number of expert spokespeople available for interviews on a variety of kidney and transplantation-related topics. If you are interested in contacting any of the experts profiled below, please get in touch with the NKF Public Relations Department at 800-622-9010 ext.235, or click here.

                  Kevin Longino
                  National Kidney Foundation

                  Kevin Longino was appointed CEO of the National Kidney Foundation in September 2015. In this role, he has realigned the organization to address the severe shortage of organs available for kidney transplantation and focused NKF’s efforts to reduce chronic kidney disease and improve patient outcomes. Prior to his appointment, Longino served on NKF’s national Board of Directors since 2012. During this time, he was also a member of NKF’s Executive and Development Committees, and served as the Board Advisor for NKF’s new CKDintercept? initiative.

                  As the third generation in his family to develop chronic kidney disease, Longino brings to his role at NKF a deep personal understanding of kidney disease and the importance of prevention, early detection, and better patient care. His personal experience dealing with the difficulties of living with end-stage renal failure and life post-transplant ignited his passion to raise awareness of kidney disease and increase organ donation.

                  Prior to joining NKF, Longino served as an advisor and investor to several startup technology companies, as well as an entrepreneur. Previously, he held key product marketing and product management roles at Compaq Computer Corp from 1987 through 2000. During this period, he led large-scale operational projects, transforming a global company to an e-commerce model, and played a leadership role in one of the largest acquisitions and mergers in the high-tech industry. He also created a new business venture for Compaq, which was self-funding within 20 months.

                  Longino earned a post-graduate Diploma in Financial Strategy from Oxford University in 2013, and holds an MBA and a BS in Marketing from Louisiana Tech University, awarded in 1985 and 1982, respectively.

                  Kerry Willis, Ph.D.
                  Chief Scientific Officer
                  National Kidney Foundation

                  Dr. Kerry Willis, Chief Scientific Officer, has been the director of medical and scientific activities for the National Kidney Foundation since 1998. She oversees all NKF-sponsored research and professional education programs, including the Spring Clinical Meetings, the KDOQI clinical practice guidelines and four peer-reviewed journals devoted to chronic kidney disease. She also directs the NKF Patient Network, the first ever patient-centered, nationwide kidney disease patient registry.

                  Prior to joining NKF, Dr. Willis was editor-in-chief of the Life Sciences Division of Academic Press. She received her Ph.D. in Molecular Genetics from New York University’s Sackler Institute for Biomedical Sciences.

                  Joseph A. Vassalotti, MD
                  Chief Medical Officer
                  National Kidney Foundation

                  Dr. Joseph Vassalotti is the Chief Medical Officer of the National Kidney Foundation (NKF) and Associate Clinical Professor of Medicine in the Division of Nephrology, at Icahn School of Medicine at Mount Sinai. He received his medical degree with Distinction in Research from the SUNY Stony Brook School of Medicine and completed an Internal Medicine Residency and Nephrology Fellowship at the Johns Hopkins Hospital. At NKF, his major focus is implementation of evidence-based clinical practice guidelines in chronic kidney disease (CKD), including NKF’s Kidney Disease Outcomes Quality Initiative (KDOQI), particularly through guidance of NKF’s primary care initiative, called CKD intercept. He has served as co-PI for the CDC Demonstration Project, “CKD Health Evaluation and Risk Information Sharing (CHERISH)”, which aimed to identify individuals at high risk for CKD in the U.S. and as an investigator for the NIH-sponsored clustered practice randomized trial entitled, evidenced-based primary care for CKD.

                  Leadership also includes multiple roles over the last decade with the CMS Fistula First national quality improvement initiative for hemodialysis, including as Lead Physician Consultant from 2013 through 2015. He has served on numerous committees that shape innovation and health policy in kidney disease for the CDC, the NIH and CMS. Currently, he serves as Principal Investigator for the Kidney Score Platform an NKF educational project funded by the Veterans Administration Center for Innovation to improve awareness and education among Veterans with and at risk for CKD in the primary care setting. Dr. Vassalotti has over 80 publications in peer-reviewed journals and has been featured in Castle Connolly’s Top Doctors and Best Doctors in America.

                  Holly Kramer, M.D., MPH

                  NKF President
                  Associate Professor of Public Health Sciences and Medicine, Division of Nephrology and Hypertension
                  Loyola University Chicago
                  Maywood, IL

                  Read Dr. Kramer's biography here.